Glytone Acne Bpo Treatment Gel
FDA Label NDC 84262-030

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Glytone, Llc for the product Glytone Acne Bpo Treatment Gel (NDC 84262-030). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications & usage, otc - active ingredient, otc - purpose, warnings, inactive ingredient, dosage & administration, otc - keep out of reach of children, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.